111 related articles for article (PubMed ID: 1566396)
1. Discordant complement systems as a factor in hyperacute xenograft rejection.
Yang Q; Wang YY; Bollinger RR; De Buysscher EV
Transplant Proc; 1992 Apr; 24(2):481-2. PubMed ID: 1566396
[No Abstract] [Full Text] [Related]
2. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
[No Abstract] [Full Text] [Related]
3. Activation of endothelial cells in hyperacute xenograft rejection.
Geller RL; Bach FH; Vercellotti GM; Nistler RS; Bolman RM; Fischel RJ; Leventhal J; Platt JL
Transplant Proc; 1992 Apr; 24(2):592. PubMed ID: 1566442
[No Abstract] [Full Text] [Related]
4. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
[No Abstract] [Full Text] [Related]
5. Presence of a complement-dependent "cytotoxic factor" in dog serum: relevance to experimental discordant xenotransplantation.
Baker J; Martin M; Ye Y; Oleinick S; Zuhdi N; Cooper DK
Transplant Proc; 1992 Apr; 24(2):490-1. PubMed ID: 1566399
[No Abstract] [Full Text] [Related]
6. Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.
Gautreau C; Kojima T; Woimant G; Cardoso J; Devillier P; Houssin D
Transplantation; 1995 Nov; 60(9):903-7. PubMed ID: 7491691
[TBL] [Abstract][Full Text] [Related]
7. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
[No Abstract] [Full Text] [Related]
8. The mechanism of discordant xenograft rejection.
Miyagawa S; Hirose H; Shirakura R; Nakata S; Naka Y; Kitagawa S; Nakano S; Matsumoto M; Seya T; Kitamura H
Transplant Proc; 1989 Feb; 21(1 Pt 1):520-1. PubMed ID: 2650190
[No Abstract] [Full Text] [Related]
9. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
10. Effect of anticomplement reagents, K-76 COOH and FUT175, on discordant xenograft survival.
Miyagawa S; Shirakura R; Matsumiya G; Kitagawa S; Fukushima N; Nakata S; Nakano S; Kitamura H; Matsumoto M; Seya T
Transplant Proc; 1992 Apr; 24(2):483-4. PubMed ID: 1566397
[No Abstract] [Full Text] [Related]
11. Xenotransplantation: role of natural immunity.
Li S; Waer M; Billiau AD
Transpl Immunol; 2009 Jun; 21(2):70-4. PubMed ID: 18992342
[TBL] [Abstract][Full Text] [Related]
12. Effects of complement suppression on xenograft survival in hyperacute rejection.
Mukai S; Orihashi K; Sueda T; Kajihara H; Matsuura Y
Hiroshima J Med Sci; 1999 Mar; 48(1):17-24. PubMed ID: 10213959
[TBL] [Abstract][Full Text] [Related]
13. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection.
Forty J; White DG; Wallwork J
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):308-16. PubMed ID: 8341072
[TBL] [Abstract][Full Text] [Related]
14. Hyperacute xenograft rejection in the swine-to-human donor-recipient combination. In vitro analysis of complement activation.
Zhao Z; Termignon JL; Cardoso J; Chéreau C; Gautreau C; Calmus Y; Houssin D; Weill B
Transplantation; 1994 Jan; 57(2):245-9. PubMed ID: 8310516
[TBL] [Abstract][Full Text] [Related]
15. Complement mediates attenuation of endothelium-dependent relaxations in canine coronary arteries after porcine serum exposure: a mechanism for vascular thrombosis in xenograft hyperacute rejection.
Cable DG; Hisamochi K; Schaff HV
Circulation; 1997 Nov; 96(9 Suppl):II-58-63; discussion II-63-4. PubMed ID: 9386076
[TBL] [Abstract][Full Text] [Related]
16. Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Mazzaferro V; Perrelli L; Musiani P
Transplant Proc; 1990 Jun; 22(3):1071-6. PubMed ID: 2190372
[No Abstract] [Full Text] [Related]
17. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
[No Abstract] [Full Text] [Related]
18. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
[No Abstract] [Full Text] [Related]
19. Discordant xenogeneic cellular interactions when hyperacute rejection is prevented: analysis using an ex vivo model of pig kidney perfused with human lymphocytes.
Khalfoun B; Janin P; Machet MC; Lacord M; Riess G; Salmon H; Nivet H; Gruel Y; Bardos P; Lebranchu Y
Transplant Proc; 1996 Apr; 28(2):647. PubMed ID: 8623322
[No Abstract] [Full Text] [Related]
20. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
